CUSIP 01438T106COMALDXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
134 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 5.48M | $28.36M | 0 | Held |
| 2 | Perceptive Advisors LLC | 4.19M | $21.68M | −1.04M | Reduced |
| 3 | Blackrock, Inc. | 3.85M | $19.94M | +45.2K | Added |
| 4 | Vanguard Group Inc | 3.70M | $19.16M |
| +106.8K |
| Added |
| 5 | Kingdon Capital Management, L.L.C. | 1.85M | $9.58M | +518.2K | Added |
| 6 | D. E. Shaw & Co., Inc. | 1.60M | $8.29M | +221.5K | Added |
| 7 | 683 Capital Management, LLC | 1.53M | $7.93M | +710.0K | Added |
| 8 | Ardsley Advisory Partners LP | 1.45M | $7.51M | −450.0K | Reduced |
| 9 | Kennedy Capital Management LLC | 1.26M | $6.51M | +143.6K | Added |
| 10 | Aqr Capital Management LLC | 1.23M | $6.36M | −278.4K | Reduced |
See every fund holding Aldeyra Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders